Add like
Add dislike
Add to saved papers

Medically unexplained visual loss in adult patients.

Eye 2004 September
PURPOSE: To evaluate the characteristics of patients with nonorganic or medically unexplained visual loss (MUVL) presenting to a neuro-ophthalmology clinic.

METHODS: A retrospective review of the case notes of patients identified from our diagnostic register. All patients had been followed up for at least 18 months and investigations (including, in all cases, neuroimaging) had failed to reveal any underlying pathology. To be included, patients had to have at least one inconsistent feature on visual function testing.

RESULTS: : We identified 58 patients with MUVL. A total of 79% of patients were female and 21% were male. In total, 36% of patients had been seen in other medical specialties with unexplained symptoms. In all, 60% of patients complained of glare or pain. Of the patients with bilateral visual loss, the acuities were frequently the same in each eye and the most common pattern of visual field loss was concentric contraction. Those with unilateral visual loss had a more variable pattern of visual failure. In total, 22% of patients showed some visual recovery though this was usually incomplete. In one patient, organic pathology accounting for the visual symptoms became apparent after the end of the 18 month follow-up period.

CONCLUSIONS: Medically unexplained symptoms, in general, form an important part of the workload in most medical specialties. Unexplained symptoms in ophthalmology have not been well studied. Terminology should be brought into line with that used in other medical specialties. Further work may help in the identification of positive diagnostic features of MUVL which should not be simply a 'diagnosis of exclusion'.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app